BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen M, Liu M, Luo Y, Cao J, Zeng F, Yang L, Yang J, Tao T, Jiang Y. Celastrol Protects against Cerebral Ischemia/Reperfusion Injury in Mice by Inhibiting Glycolysis through Targeting HIF-1α/PDK1 Axis. Oxid Med Cell Longev 2022;2022:7420507. [PMID: 35035665 DOI: 10.1155/2022/7420507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan C, Li L, Han J, Xu K, Liu X. A new strategy for osteoarthritis therapy: Inhibition of glycolysis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1057229] [Reference Citation Analysis]
2 Cui Y, Jiang X, Feng J. The therapeutic potential of triptolide and celastrol in neurological diseases. Front Pharmacol 2022;13:1024955. [DOI: 10.3389/fphar.2022.1024955] [Reference Citation Analysis]
3 Li Z, Zhang J, Duan X, Zhao G, Zhang M. Celastrol: A Promising Agent Fighting against Cardiovascular Diseases. Antioxidants 2022;11:1597. [DOI: 10.3390/antiox11081597] [Reference Citation Analysis]
4 Liu J, Guo X, Yang L, Tao T, Cao J, Hong Z, Zeng F, Lu Y, Lin C, Qin Z. Effect of Celastrol on LncRNAs and mRNAs Profiles of Cerebral Ischemia-Reperfusion Injury in Transient Middle Cerebral Artery Occlusion Mice Model. Front Neurosci 2022;16:889292. [DOI: 10.3389/fnins.2022.889292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]